Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CNC Centene	$33.28 -1.5%	$55.93	$33.30 ▼ $80.59	$16.58B	0.44	5.46 million shs	33.74 million shs
ELV Elevance Health	$348.92 -0.4%	$387.65	$347.21 ▼ $567.26	$78.59B	0.6	1.61 million shs	2.01 million shs
HUM Humana	$238.58 -2.1%	$240.29	$212.45 ▼ $406.46	$28.93B	0.44	1.82 million shs	960,833 shs
SYK Stryker	$392.00 +0.0%	$382.92	$314.93 ▼ $406.19	$150.87B	0.91	1.35 million shs	536,295 shs

10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CNC Centene	0.00%	-38.36%	-39.28%	-46.44%	-50.16%
ELV Elevance Health	0.00%	-8.48%	-9.28%	-18.59%	-34.19%
HUM Humana	0.00%	-1.34%	+5.18%	-5.84%	-34.25%
SYK Stryker	0.00%	-0.43%	+2.42%	+13.25%	+18.05%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CNC Centene	4.9747 of 5 stars	4.2	3.0	0.0	3.7	2.2	1.7	4.4
ELV Elevance Health	4.9724 of 5 stars	4.4	3.0	4.2	0.0	3.2	2.5	3.8
HUM Humana	4.6468 of 5 stars	3.2	3.0	2.5	3.9	2.8	1.7	1.3
SYK Stryker	4.5813 of 5 stars	2.4	3.0	3.3	4.2	2.5	2.5	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CNC Centene	2.41	Hold	$68.87	106.96% Upside
ELV Elevance Health	2.75	Moderate Buy	$498.87	42.97% Upside
HUM Humana	2.30	Hold	$280.76	17.68% Upside
SYK Stryker	2.79	Moderate Buy	$427.30	9.00% Upside

Current Analyst Ratings Breakdown

Latest ELV, HUM, CNC, and SYK Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/2/2025	CNC Centene	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$65.00 ➝ $52.00
7/2/2025	CNC Centene	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$65.00 ➝ $45.00
7/2/2025	CNC Centene	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$90.00 ➝ $65.00
7/2/2025	CNC Centene	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Neutral	$75.00 ➝ $48.00
7/2/2025	CNC Centene	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Neutral	$80.00 ➝ $45.00
6/17/2025	HUM Humana	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$320.00 ➝ $260.00
6/17/2025	HUM Humana	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Hold ➝ Hold	$305.00 ➝ $280.00
6/12/2025	HUM Humana	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Equal Weight ➝ Equal Weight	$273.00 ➝ $268.00
6/9/2025	CNC Centene	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight	$70.00
6/9/2025	ELV Elevance Health	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$510.00 ➝ $500.00
6/4/2025	ELV Elevance Health	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$478.00

(Data available from 7/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CNC Centene	$163.07B	0.10	$9.87 per share	3.37	$52.49 per share	0.63
ELV Elevance Health	$183.12B	0.43	$39.29 per share	8.88	$178.62 per share	1.95
HUM Humana	$120.26B	0.24	$23.76 per share	10.04	$136.57 per share	1.75
SYK Stryker	$23.22B	6.44	$14.96 per share	26.21	$54.13 per share	7.24

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CNC Centene	$3.31B	$6.71	4.96	4.51	0.45	2.04%	14.56%	4.75%	7/25/2025 (Estimated)
ELV Elevance Health	$5.98B	$25.63	13.61	8.94	0.88	3.23%	18.61%	6.80%	7/17/2025 (Confirmed)
HUM Humana	$1.21B	$14.14	16.87	18.17	1.81	1.42%	14.47%	5.03%	7/30/2025 (Estimated)
SYK Stryker	$2.99B	$7.40	52.97	26.43	2.98	12.31%	23.74%	11.25%	7/29/2025 (Estimated)

Latest ELV, HUM, CNC, and SYK Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
7/30/2025	Q2 2025	HUM Humana	$6.32	N/A	N/A	N/A	$31.85 billion	N/A
7/29/2025	Q2 2025	SYK Stryker	$3.06	N/A	N/A	N/A	$5.92 billion	N/A
7/25/2025	Q2 2025	CNC Centene	$2.07	N/A	N/A	N/A	$44.71 billion	N/A
7/16/2025	Q2 2025	ELV Elevance Health	$9.30	N/A	N/A	N/A	$48.26 billion	N/A
5/1/2025	Q1 2025	SYK Stryker	$2.73	$2.84	+$0.11	$1.69	$5.68 billion	$5.87 billion
4/30/2025	Q1 2025	HUM Humana	$10.07	$11.58	+$1.51	$10.30	$32.00 billion	$32.11 billion
4/25/2025	Q1 2025	CNC Centene	$2.52	$2.90	+$0.38	$2.63	$43.16 billion	$46.62 billion
4/22/2025	Q1 2025	ELV Elevance Health	$10.60	$11.97	+$1.37	$9.61	$46.26 billion	$48.77 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CNC Centene	N/A	N/A	N/A	N/A	N/A
ELV Elevance Health	$6.84	1.96%	N/A	26.69%	14 Years
HUM Humana	$3.54	1.48%	N/A	25.04%	N/A
SYK Stryker	$3.36	0.86%	N/A	45.41%	32 Years

Latest ELV, HUM, CNC, and SYK Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/8/2025	SYK Stryker	quarterly	$0.84	0.88%	6/30/2025	6/30/2025	7/31/2025
4/17/2025	HUM Humana	quarterly	$0.8850	1.24%	6/27/2025	6/27/2025	7/25/2025
4/23/2025	ELV Elevance Health	quarterly	$1.71	1.6%	6/10/2025	6/10/2025	6/25/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CNC Centene	0.65	1.11	1.11
ELV Elevance Health	0.66	1.43	1.43
HUM Humana	0.71	1.91	1.91
SYK Stryker	0.69	1.64	1.00

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CNC Centene	93.63%
ELV Elevance Health	89.24%
HUM Humana	92.38%
SYK Stryker	77.09%

Insider Ownership

Company	Insider Ownership
CNC Centene	0.36%
ELV Elevance Health	0.29%
HUM Humana	0.37%
SYK Stryker	5.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CNC Centene	60,500	497.60 million	495.81 million	Optionable
ELV Elevance Health	104,200	225.94 million	225.28 million	Optionable
HUM Humana	65,680	120.69 million	120.25 million	Optionable
SYK Stryker	53,000	381.69 million	359.17 million	Optionable

ELV, HUM, CNC, and SYK Headlines

Recent News About These Companies

Chilton Capital Management LLC Boosts Stake in Stryker Corporation (NYSE:SYK)

2 hours ago | marketbeat.com

Financiere des Professionnels Fonds d investissement inc. Sells 1,880 Shares of Stryker Corporation (NYSE:SYK)

2 hours ago | marketbeat.com

Rice Partnership LLC Invests $3.97 Million in Stryker Corporation (NYSE:SYK)

3 hours ago | marketbeat.com

Stryker Corporation (NYSE:SYK) Shares Bought by Concurrent Investment Advisors LLC

4 hours ago | marketbeat.com

Simmons Bank Boosts Holdings in Stryker Corporation (NYSE:SYK)

4 hours ago | marketbeat.com

Yehey.com - Stryker Appoints New Leaders to Drive Digital Robotics Innovation

July 5 at 7:01 PM | yehey.comY

Bank of New York Mellon Corp Sells 202,474 Shares of Stryker Corporation (NYSE:SYK)

July 5 at 8:32 AM | marketbeat.com

Kintegral Advisory LLC Has $767,000 Holdings in Stryker Corporation (NYSE:SYK)

July 5 at 6:36 AM | marketbeat.com

OneDigital Investment Advisors LLC Purchases 1,946 Shares of Stryker Corporation (NYSE:SYK)

July 5 at 6:14 AM | marketbeat.com

IFM Investors Pty Ltd Increases Stock Position in Stryker Corporation (NYSE:SYK)

July 4 at 8:03 AM | marketbeat.com

Calamos Wealth Management LLC Buys 32,592 Shares of Stryker Corporation (NYSE:SYK)

July 4 at 7:18 AM | marketbeat.com

Calamos Advisors LLC Buys 8,264 Shares of Stryker Corporation (NYSE:SYK)

July 4 at 7:18 AM | marketbeat.com

Principal Financial Group Inc. Sells 785 Shares of Stryker Corporation (NYSE:SYK)

July 4 at 5:56 AM | marketbeat.com

Stryker’s Incompass System Secures FDA Nod, Boosting Orthopaedics Innovation Strategy

July 4 at 4:49 AM | msn.com

Argentina To Acquire Stryker Armored Vehicles From US

July 3 at 9:26 AM | rttnews.com

Teacher Retirement System of Texas Has $76.11 Million Stock Holdings in Stryker Corporation (NYSE:SYK)

July 3 at 7:29 AM | marketbeat.com

Private Trust Co. NA Buys 659 Shares of Stryker Corporation (NYSE:SYK)

July 3 at 6:10 AM | marketbeat.com

Stryker Corporation (NYSE:SYK) Shares Bought by DAVENPORT & Co LLC

July 3 at 5:18 AM | marketbeat.com

Allspring Global Investments Holdings LLC Has $16.19 Million Holdings in Stryker Corporation (NYSE:SYK)

July 3 at 4:23 AM | marketbeat.com

Here's How Much You Would Have Made Owning Stryker Stock In The Last 5 Years

July 2, 2025 | benzinga.com

Horizon Financial Services LLC Boosts Holdings in Stryker Corporation (NYSE:SYK)

July 2, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

ELV, HUM, CNC, and SYK Company Descriptions

Centene NYSE:CNC

$33.28 -0.51 (-1.49%)

Closing price 07/3/2025 03:58 PM Eastern

Extended Trading

$33.28 0.00 (0.00%)

As of 07/3/2025 04:59 PM Eastern

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support. This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. It also operates clinical healthcare and pharmacies, as well as offers dental and speech therapy services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts. It provides services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.

Elevance Health NYSE:ELV

$348.92 -1.33 (-0.38%)

Closing price 07/3/2025 03:55 PM Eastern

Extended Trading

$350.15 +1.23 (+0.35%)

As of 07/3/2025 04:59 PM Eastern

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.

Humana NYSE:HUM

$238.58 -5.22 (-2.14%)

Closing price 07/3/2025 03:56 PM Eastern

Extended Trading

$238.58 0.00 (0.00%)

As of 07/3/2025 04:58 PM Eastern

Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Stryker NYSE:SYK

$392.00 +0.19 (+0.05%)

Closing price 07/3/2025 03:57 PM Eastern

Extended Trading

$394.48 +2.47 (+0.63%)

As of 07/3/2025 05:00 PM Eastern

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time